Suppr超能文献

凝血酶对人胎儿肺成纤维细胞中组织型和尿激酶型纤溶酶原激活剂基因的转录调控

Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.

作者信息

Hayakawa Y, Tazawa S, Ishikawa T, Niiya K, Sakuragawa N

机构信息

Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan.

出版信息

Thromb Haemost. 1995 Aug;74(2):704-10.

PMID:8585010
Abstract

The mechanism of thrombin induction of tissue- and urokinase-type plasminogen activator (t-PA and u-PA) biosynthesis was investigated in cultured human fetal lung fibroblast cells, IMR-90. Northern blot analysis of total RNA from thrombin-treated cells showed marked accumulations of both t-PA and u-PA mRNA during 24 h. Nuclear run-on experiments showed that the transcription rates of both genes were increased in the thrombin-treated cells. These thrombin effects were inhibited by cycloheximide (CHX), an inhibitor of protein biosynthesis. Treatment of IMR-90 cells with CHX alone caused an increase in u-PA mRNA but not in t-PA mRNA. CHX, however, did not affect the transcription rates of both genes in the cells. Thus, on-going protein synthesis is required for increased accumulations of both t-PA and u-PA mRNA by thrombin but not for the constitutive expression of u-PA gene in IMR-90 cells. Therefore, we conclude that the accumulations of t-PA and u-PA mRNA due to thrombin result mainly from increased rates of their gene transcriptions, and that this influence is exerted in part by proteins synthesized by thrombin stimulation. Thrombin also increased plasminogen activator inhibitor type-1 (PAI-1) in the levels of both antigen and mRNA more rapidly than it increased t-PA in IMR-90 cells. In conditioned medium, most of the secreted PAI-1 seemed to form a complex with t-PA. Northern blot analysis using a PAI-2 cDNA probe showed that the levels of PAI-2 mRNA were markedly increased in response to thrombin.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在培养的人胎儿肺成纤维细胞IMR-90中,研究了凝血酶诱导组织型和尿激酶型纤溶酶原激活物(t-PA和u-PA)生物合成的机制。对凝血酶处理细胞的总RNA进行Northern印迹分析显示,在24小时内t-PA和u-PA mRNA均显著积累。核转录实验表明,凝血酶处理细胞中这两个基因的转录速率均增加。这些凝血酶的作用被蛋白质生物合成抑制剂环己酰亚胺(CHX)所抑制。单独用CHX处理IMR-90细胞会导致u-PA mRNA增加,但t-PA mRNA不增加。然而,CHX并不影响细胞中这两个基因的转录速率。因此,凝血酶增加t-PA和u-PA mRNA的积累需要持续的蛋白质合成,但IMR-90细胞中u-PA基因的组成性表达则不需要。所以,我们得出结论,凝血酶导致的t-PA和u-PA mRNA积累主要源于其基因转录速率的增加,并且这种影响部分是由凝血酶刺激合成的蛋白质所施加的。在IMR-90细胞中,凝血酶增加纤溶酶原激活物抑制剂1型(PAI-1)的抗原和mRNA水平的速度比增加t-PA的速度更快。在条件培养基中,大部分分泌的PAI-1似乎与t-PA形成复合物。使用PAI-2 cDNA探针进行的Northern印迹分析表明,PAI-2 mRNA的水平在凝血酶作用下显著增加。(摘要截短至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验